1. Home
  2. DINO vs KRYS Comparison

DINO vs KRYS Comparison

Compare DINO & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HF Sinclair Corporation

DINO

HF Sinclair Corporation

HOLD

Current Price

$58.48

Market Cap

8.7B

Sector

Energy

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$274.04

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DINO
KRYS
Founded
1947
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.7B
7.8B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
DINO
KRYS
Price
$58.48
$274.04
Analyst Decision
Buy
Strong Buy
Analyst Count
11
11
Target Price
$59.50
$257.45
AVG Volume (30 Days)
2.3M
249.5K
Earning Date
02-18-2026
02-17-2026
Dividend Yield
3.42%
N/A
EPS Growth
21.43
275.72
EPS
2.07
6.66
Revenue
$26,905,000,000.00
$373,164,000.00
Revenue This Year
N/A
$36.13
Revenue Next Year
$0.11
$41.52
P/E Ratio
$28.29
$41.50
Revenue Growth
N/A
54.51
52 Week Low
$24.66
$122.80
52 Week High
$59.33
$295.98

Technical Indicators

Market Signals
Indicator
DINO
KRYS
Relative Strength Index (RSI) 67.13 57.43
Support Level $56.74 $264.85
Resistance Level $59.33 $280.00
Average True Range (ATR) 1.57 10.17
MACD 0.46 -1.91
Stochastic Oscillator 81.11 70.94

Price Performance

Historical Comparison
DINO
KRYS

About DINO HF Sinclair Corporation

HF Sinclair is an integrated petroleum refiner that owns and operates seven refineries serving the Rockies, midcontinent, Southwest, and Pacific Northwest, with a total crude oil throughput capacity of 678,000 barrels per day. It can produce 380 million gallons of renewable diesel annually. It holds a marketing business with over 300 distributors and 1,500 wholesale branded sites across 30 states. It also owns and operates 4,400 miles of petroleum product pipelines and terminals principally in the southwestern United States.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: